Palisade Asset Management’s Eli Lilly LLY Stock Holding History

Palisade Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17M	Sell	14,193 -225	-2%	-$230K	1.57%	18
2026 Q1	$13.3M	Sell	14,418 -309	-2%	-$313K	1.33%	25
2025 Q4	$15.8M	Sell	14,727 -4,162	-22%	-$3.98M	1.54%	17
2025 Q3	$14.4M	Buy	18,889 +566	+3%	+$421K	1.34%	27
2025 Q2	$14.3M	Sell	18,323 -15	-0.1%	-$11.7K	1.42%	22
2025 Q1	$15.1M	Sell	18,338 -720	-4%	-$599K	1.56%	22
2024 Q4	$14.7M	Sell	19,058 -12	-0.1%	-$9.94K	1.49%	21
2024 Q3	$16.9M	Sell	19,070 -161	-0.8%	-$145K	1.65%	18
2024 Q2	$17.4M	Sell	19,231 -3,278	-15%	-$2.62M	1.8%	14
2024 Q1	$17.5M	Sell	22,509 -200	-0.9%	-$142K	1.71%	15
2023 Q4	$13.2M	Buy	22,709 +229	+1%	+$134K	1.45%	21
2023 Q3	$12.1M	Sell	22,480 -203	-0.9%	-$105K	1.47%	21
2023 Q2	$10.6M	Hold	22,683	–	–	1.23%	25
2023 Q1	$7.79M	Hold	22,683	–	–	0.95%	38
2022 Q4	$8.3M	Hold	22,683	–	–	0.95%	38
2022 Q3	$7.33M	Hold	22,683	–	–	1.01%	38
2022 Q2	$7.36M	Hold	22,683	–	–	0.95%	39
2022 Q1	$6.5M	Sell	22,683 -850	-4%	-$219K	0.75%	47
2021 Q4	$6.5M	Sell	23,533 -350	-1%	-$88.7K	0.73%	48
2021 Q3	$5.52M	Hold	23,883	–	–	0.67%	50
2021 Q2	$5.48M	Sell	23,883 -100	-0.4%	-$20.1K	0.64%	52
2021 Q1	$4.48M	Buy	23,983 +44	+0.2%	+$8.61K	0.58%	56
2020 Q4	$4.04M	Sell	23,939 -100	-0.4%	-$14.9K	0.55%	59
2020 Q3	$3.56M	Sell	24,039 -1,000	-4%	-$155K	0.54%	58
2020 Q2	$4.11M	Sell	25,039 -625	-2%	-$95.9K	0.66%	53
2020 Q1	$3.56M	Hold	25,664	–	–	0.65%	52
2019 Q4	$3.37M	Hold	25,664	–	–	0.49%	60
2019 Q3	$2.87M	Sell	25,664 -270	-1%	-$30.1K	0.44%	64
2019 Q2	$2.87M	Sell	25,934 -425	-2%	-$50K	0.45%	63
2019 Q1	$3.42M	Buy	26,359 +1,000	+4%	+$122K	0.54%	55
2018 Q4	$2.94M	Hold	25,359	–	–	0.43%	58
2018 Q3	$2.72M	Sell	25,359 -200	-0.8%	-$20K	0.36%	61
2018 Q2	$2.18M	Hold	25,559	–	–	0.32%	68
2018 Q1	$1.98M	Buy	25,559 +300	+1%	+$24.2K	0.3%	69
2017 Q4	$2.13M	Buy	25,259 +3,700	+17%	+$315K	0.34%	65
2017 Q3	$1.84M	Hold	21,559	–	–	0.34%	65
2017 Q2	$1.77M	Hold	21,559	–	–	0.35%	65
2017 Q1	$1.81M	Sell	21,559 -200	-0.9%	-$16K	0.33%	58
2016 Q4	$1.6M	Hold	21,759	–	–	0.31%	66
2016 Q3	$1.75M	Sell	21,759 -200	-0.9%	-$16K	0.32%	63
2016 Q2	$1.73M	Hold	21,959	–	–	0.33%	65
2016 Q1	$1.58M	Buy	21,959 +830	+4%	+$62.8K	0.31%	66
2015 Q4	$1.78M	Sell	21,129 -460	-2%	-$38.2K	0.38%	56
2015 Q3	$1.81M	Hold	21,589	–	–	0.4%	63
2015 Q2	$1.8M	Hold	21,589	–	–	0.36%	64
2015 Q1	$1.57M	Buy	21,589 +1,000	+5%	+$71.2K	0.31%	71
2014 Q4	$1.42M	Hold	20,589	–	–	0.28%	72
2014 Q3	$1.33M	Sell	20,589 -400	-2%	-$25.3K	0.27%	70
2014 Q2	$1.3M	Sell	20,989 -180	-0.9%	-$10.7K	0.27%	70
2014 Q1	$1.25M	Hold	21,169	–	–	0.27%	70
2013 Q4	$1.08M	Hold	21,169	–	–	0.24%	73
2013 Q3	$1.06M	Sell	21,169 -1,000	-5%	-$52.4K	0.27%	71
2013 Q2	$1.09M	Buy	+22,169	New	+$1.21M	0.27%	70

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Palisade Asset Management's LLY Position: Q2 2026 in Review

Palisade Asset Management reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $230K and leaving 14,193 shares worth $17M. The position accounts for 1.57% of the portfolio, ranked #18.

Palisade Asset Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.5M in Q1 2024. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Palisade Asset Management held 14,193 shares of Eli Lilly worth $17M as of Q2 2026.
Palisade Asset Management sold 225 Eli Lilly shares in Q2 2026, an estimated $230K.
Eli Lilly made up 1.57% of Palisade Asset Management's portfolio in Q2 2026, its #18 holding.
Palisade Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
Palisade Asset Management's Eli Lilly position peaked at $17.5M in Q1 2024.
1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.